New Recruiting Trial: Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease
WHY IT MATTERS
This trial is now actively recruiting pregnant women with sickle cell disease — participation could help prevent pregnancy complications like stroke, organ damage, and miscarriage that occur at higher rates in this population.
Researchers at Emory University are looking for pregnant women with sickle cell disease to join a study about blood transfusions. The study will test whether giving blood transfusions during pregnancy can help prevent serious complications for both the mother and baby. This is a Phase 4 trial, which means the treatment has already been tested before and researchers want to learn more about how well it works.
NCT ID: NCT06979492 Title: Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease Status: RECRUITING Phase: PHASE4 Sponsor: Emory University Start date: 2026-04-01 URL: https://clinicaltrials.gov/study/NCT06979492 Source: UniteRare clinical trials database
YOU CAN ACT ON THIS
If you are a pregnant woman with sickle cell disease, contact Emory University or visit clinicaltrials.gov/study/NCT06979492 to learn about enrollment requirements and whether you qualify.